0.15Open0.50Pre Close35 Volume2.19K Open Interest81.00Strike Price709.00Turnover47.51%IV6.33%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.1238Delta0.0546Gamma339.60Leverage Ratio-0.0957Theta0.0010Rho42.05Eff Leverage0.0161Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet